TUESDAY, Aug. 20, 2024 -- Using a new classification of steatotic liver disease (SLD) based on the presence of metabolic dysfunction and alcohol...
Vous n'êtes pas connecté
The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects one in four people.
TUESDAY, Aug. 20, 2024 -- Using a new classification of steatotic liver disease (SLD) based on the presence of metabolic dysfunction and alcohol...
A study led by the University of Michigan suggests that people with higher levels of metals in their blood and urine may have a higher chance of being...
Liver disease is a common condition affecting millions of adults in the United States. One serious form of this disease is nonalcoholic fatty liver...
If you’ve ever felt like it “hurts to think,” you might be onto something. A new study published in the journal Psychological Bulletin suggests...
TUESDAY, Aug. 20, 2024 -- Toxin from one of the most venomous animals on the planet – a deadly sea snail – could help researchers figure out new...
A new video analysis method using machine learning can detect early signs of Parkinson’s disease, including those invisible to the human eye....
Alzheimer’s disease is a progressive brain disorder that leads to memory loss, confusion, and difficulty with thinking and reasoning. It’s the...
Frontotemporal dementia (FTD) is a form of early-onset dementia that primarily affects people between the ages of 40 and 65. It’s the most common...
A recent study from Umeå University in Sweden has uncovered important insights into the role of hereditary traits and certain lifestyle factors in...
A class-action lawsuit against one of the world’s largest agri-businesses is going ahead, thanks to a Vancouver Island man who passed away last...